“Sr.No.” | Dosage Form | Generic Name | Composition | Spc. | Qty. | Unit |
---|---|---|---|---|---|---|
01 | Tablets | Nimesulide Tablets (Not to be used for children below 12 years of age) |
Each uncoated tablet contains : Nimesulide Excipients Approved Colour used |
B.P | ||
02 | Tablets | Etodolac ER Tablets 400MG | Each film coated extended release tablet contains: | |||
Etodolac | I.P | 400 | mg | |||
Excipients | q.s. | |||||
Approved Colour used | ||||||
03 | Tablets | Etodolac and Paracetamol Tablets | Each film coated tablet contains: | |||
Etodolac | I.P | 400 | mg | |||
Paracetamol | I.P | 325 | mg | |||
Excipients | q.s. | |||||
Approved Colour used | ||||||
04 | Tablets | Amisulpiride Tablets I.P 100 mg | Each film coated tablet contains: | |||
Amisulpride | I.P | 100 | mg | |||
Excipients | q.s. | |||||
Approved colour used | ||||||
05 | Tablets | Aceclofenac & Drotaverine HCl Tablets | Each film coated tablet contains : | |||
Aceclofenac | I.P | 100 | mg | |||
Drotaverine Hydrochloride | I.P | 80 | mg | |||
Excipients | q.s. | |||||
Approved Colour used | ||||||
06 | Tablets | Ketoconazole Tablets I.P 200mg | Each film coated tablet contains: | |||
Ketoconazole | I.P | 200 | mg | |||
Excipients | q.s. | |||||
Approved colour used | ||||||
07 | Tablets | Levetiracetam Tablets I.P 500 mg | Each filmcoated tablet contains : | |||
Levetiracetam | I.P | 500 | mg | |||
Excipients | q.s. | |||||
Approved Colour used | ||||||
08 | Tablets | Paracetamol, Phenylephrine HCl, Diphenhydramine HCl and Caffeine Tablets | Each uncoated tablet contains : | |||
Paracetamol | I.P. | 500 | mg | |||
Phenylephrine Hydrochloride | I.P. | 5 | mg | |||
Diphenhydramine Hydrochloride | I.P. | 25 | mg | |||
Caffeine (anhydrous) | I.P. | 30 | mg | |||
Excipients | q.s. | |||||
Approved Colour used | ||||||
9 | Tablets | Alpha Lipoic Acid, Folic Acid, Methylcobalamin, Pyridoxine HCl and Vitamin D3 Tablets |
Each film coated tablet contains : | |||
Alpha Lipoic Acid | USP | 100 | mg | |||
Folic Acid | I.P | 1.5 | mg | |||
Methylcobalamin | I.P | 1500 | mcg | |||
Pyridoxine Hydrochloride | I.P | 3 | mg | |||
Vitamin D3 | I.P | 1000 | IU | |||
Excipients | q.s. | |||||
Approved Colour used | ||||||
10 | Tablets | Montelukast and Levocetirizine Tablets I.P | Each film coated tablet contains : | |||
Montelukast Sodium eq.to Montelukast | I.P. | 10 | mg | |||
Levocetirizine Hydrochloride | I.P. | 5 | mg | |||
Excipients | q.s. | |||||
Approved Colour used | ||||||
11 | Tablets | Etoricoxib and Thiocolchicoside Tablets | Each film coated tablet contains: | |||
Etoricoxib | I.P. | 60 | mg | |||
Thiocolchicoside | I.P. | 4 | mg | |||
Excipients | ||||||
Approved Colour used | ||||||
12 | Tablets | Telmisartan and Amlodipine Besilate Tablets I.P | Each uncoated tablet contains : | |||
Telmisartan | I.P. | 40 | mg | |||
Amlodipine Besilate eq.to Amlodipine | I.P. | 5 | mg | |||
Excipients | q.s. | |||||
Approved Colour used | ||||||
13 | Tablets | Aceclofenac and Thiocolchicoside Tablets | Each film coated tablet contains : | |||
Aceclofenac | I.P. | 100 | mg | |||
Thiocolchicoside | I.P. | 4 | mg | |||
Excipients | q.s. | |||||
Approved Colour used | ||||||
14 | Tablets | Aceclofenac and Paracetamol Tablets | Each film coated tablet contains : | |||
Aceclofenac | I.P. | 100 | mg | |||
Paracetamol | I.P. | 325 | mg | |||
Excipients | q.s. | |||||
Approved Colour used | ||||||
15 | Tablets | “Aceclofenac, Paracetamol and Chlorzoxazone Tablets | Each film coated tablet contains : | |||
Aceclofenac | I.P. | 100 | mg | |||
Paracetamol | I.P. | 325 | mg | |||
Chlorzoxazone | U.S.P. | 250 | mg | |||
Excipients | q.s. | |||||
Approved Colour used | ||||||
16 | Tablets | “Aceclofenac, Paracetamol and Serratiopeptidase Tablets | Each film coated tablet contains : | |||
Aceclofenac | I.P. | 100 | mg | |||
Paracetamol | I.P. | 325 | mg | |||
“Serratiopeptidase | I.P. | 15 | mg | |||
Excipients | q.s. | |||||
Approved Colour used | ||||||
17 | Tablets | “Aceclofenac, Paracetamol and Serratiopeptidase Tablets | Each film coated tablet contains : | |||
Aceclofenac | I.P. | 100 | mg | |||
Paracetamol | I.P. | 325 | mg | |||
“Serratiopeptidase | I.P. | 10 | mg | |||
Excipients | q.s. | |||||
Approved Colour used | ||||||
18 | Tablets | Ursodeoxycholic Acid Tablets | Each film coated tablet contains: | |||
Ursodeoxycholic Acid | I.P | 300 | mg | |||
Excipients | q.s. | |||||
Approved colour used | ||||||
Aceclofenac | I.P. | 100 | mg | |||
Paracetamol | I.P. | 325 | mg | |||
Thiocolchicoside | I.P. | 4 | mg | |||
Excipients | q.s. | |||||
Approved Colour used | ||||||
20 | Tablets | Ferrous Ascorbate, Folic acid and Zinc Sulphate Monohydrate Tablets | Each film coated tablet contains: | |||
Ferrous ascorbate eq.to elemental iron | 100 | mg | ||||
Folic Acid | I.P. | 1.5 | mg | |||
Zinc Sulphate Monohydrate eq. to elemental zinc | I.P. | 22.5 | mg | |||
Excipients | q.s. | |||||
Approved Colour used | ||||||
21 | Tablets | Azithromycin Tablets I.P. | Each film coated tablet contains : | |||
“Azithromycin Dihydrate | I.P. | 250 | mg | |||
Excipients | q.s. | |||||
Approved Colour used | ||||||
22 | Tablets | Azithromycin Tablets I.P. | Each film coated tablet contains : | |||
“Azithromycin Dihydrate | I.P. | 500 | mg | |||
Excipients | q.s. | |||||
Approved Colour used | ||||||
23 | Tablets | Gabapentin and Methylcobalamin Tablets | Each film coated tablet contains : | |||
Gabapentin | I.P | 300 | mg | |||
Methylcobalamin | I.P. | 500 | mcg | |||
Excipients | q.s. | |||||
Approved Colour used | ||||||
24 | Tablets | Calcium Citrate, Zinc,Vitamin D3 and Magnesium Tablets | Each uncoated tablet contains : | |||
Calcium Citrate | USP | 1000 | mg | |||
Zinc Sulphate Monohydrate eq.to elemental Zinc | I.P. | 4 | mg | |||
Vitamin D3 | I.P. | 200 | IU | |||
Magnesium Hydroxide eq.to elemental Magnesium | I.P. | 100 | mg | |||
Excipients | q.s. | |||||
Approved Colour used | ||||||
25 | Tablets | Pregabalin (SR) and Methylcobalamin Tablets | Each uncoated tablet contains: | |||
Pregabalin (sustained released) | I.P. | 75 | mg | |||
Methylcobalamin | I.P. | 1500 | mcg | |||
Excipients | q.s. | |||||
Approved Colour used | ||||||
Appropriate overages of vitamin added to compensate loss on storage. | ||||||
26 | Tablets | Ofloxacin Tablets I.P. | Each film coated tablet contains: | |||
Ofloxacin | I.P. | 200 | mg | |||
Excipients | q.s. | |||||
Approved Colour used | ||||||
27 | Tablets | “Ferrous Ascorbate, Cyanocobalamin, Folic Acid, Zinc Sulphate Monohydrate Tablets” | Each film coated tablet contains: | |||
Ferrous Ascorbate | 100 | mg | ||||
Cyanocobalamin | I.P | 15 | mcg | |||
Folic Acid | I.P. | 1.5 | mg | |||
Zinc Sulphate Monohydrate eq. to Elemental Zinc | I.P. | 22.5 | mg | |||
Excipients | q.s. | |||||
Approved Colour used | ||||||
28 | Tablets | Azithromycin & Lactic Acid Bacillus Tablets | Each film coated tablet contains : | |||
“Azithromycin Dihydrate | I.P. | 500 | mg | |||
Lactic Acid Bacillus | 6oMillion Spores | |||||
Excipients | q.s. | |||||
Approved Colour used | ||||||
29 | Tablets | Pregabalin, Nortriptyline & Mecobalamin Tablets | Each film coated tablet contains: | |||
Pregabalin | I.P | 75 | mg | |||
Nortriptyline Hydrochloride Eq. to Nortriptyline | I.P | 10 | mg | |||
Mecobalamin | I.P | 1500 | mcg | |||
Excipients | q.s. | |||||
Approved Colour used | ||||||
30 | Tablets | Levofloxacin Tablets I.P. 250 mg | Each film coated tablet contains : | |||
Levofloxacin Hemihydrate eq.to Levofloxacin | I.P. | 250 | mg | |||
Excipients | q.s. | |||||
Approved Colour used | ||||||
31 | Tablets | Levofloxacin Tablets I.P. 500 mg | Each film coated tablet contains: | |||
Levofloxacin Hemihydrate eq.to Levofloxacin | I.P. | 500 | mg | |||
Excipients | q.s. | |||||
Approved Colour used | ||||||
32 | Tablets | Levofloxacin Tablets I.P. 750 mg | Each film coated tablet contains: | |||
Levofloxacin Hemihydrate eq.to Levofloxacin | I.P. | 750 | mg | |||
Excipients | q.s. | |||||
Approved Colour used | ||||||
33 | Tablets | Ofloxacin & Ornidazole Tablets I.P | Each film coated tablet contains : | |||
Ofloxacin | I.P. | 200 | mg | |||
Ornidazole | I.P. | 500 | mg | |||
Excipients | q.s. | |||||
Approved Colour used | ||||||
34 | Tablets | Rabeprazole Gastro-resistant Tablets I.P. 20mg | Each enteric coated tablet contains : | |||
Rabeprazole Sodium | I.P. | 20 | mg | |||
Excipients | q.s. | |||||
Approved Colour used | ||||||
35 | Tablets | Deflazacort Tablets | Each uncoated tablet contains: | |||
Deflazacort | 6 | mg | ||||
Excipients | q.s. | |||||
Approved Colour used | ||||||
36 | Tablets | Deflazacort Tablets | Each uncoated tablet contains: | |||
Deflazacort | 30 | mg | ||||
Excipients | q.s. | |||||
Approved Colour used | ||||||
37 | Tablets | Roxithromycin Tablets I.P. 150 mg | Each film coated tablet contains : | |||
Roxithromycin | I.P. | 150 | mg | |||
Excipients | q.s. | |||||
Approved Colour used | ||||||
38 | Tablets | “Paracetamol and Nimesulide Tablets | Each uncoated tablet contains : | |||
Paracetamol | I.P. | 325 | mg | |||
Nimesulide | B.P. | 100 | mg | |||
Excipients | q.s. | |||||
Approved Colour used | ||||||
39 | Tablets | “Sildenafil Citrate Tablets | Each film-coated tablet contains : | |||
Sildenafil Citrate eq.to Sildenafil | I.P. | 100 | mg | |||
Excipients | q.s. | |||||
Approved Colour used | ||||||
Ondansetron hydrochloride eq. to Ondansetron | I.P. | 4 | mg | |||
Excipients | q.s. | |||||
Approved Colour used | ||||||
41 | Tablets | Ondansetron Orally Disintegrating Tablets I.P. 8 mg | Each uncoated tablet contains : | |||
Ondansetron Hydrochloride eq.to Ondansetron | I.P. | 8 | mg | |||
Excipients | q.s. | |||||
Approved Colour used | ||||||
42 | Tablets | Etoricoxib Tablets I.P 60 mg | Each filmcoated tablet contains: | |||
Etoricoxib | I.P. | 60 | mg | |||
Excipients | q.s. | |||||
Approved Colour used | ||||||
43 | Tablets | Etoricoxib Tablets I.P 90 mg | Each film coated tablet contains: | |||
Etoricoxib | I.P. | 90 | mg | |||
Excipients | q.s. | |||||
Approved Colour used | ||||||
44 | Tablets | Etoricoxib Tablets I.P 120 mg | Each film coated tablet contains: | |||
Etoricoxib | I.P. | 120 | mg | |||
Excipients | q.s. | |||||
Approved Colour used | ||||||
45 | Tablets | Escitalopram Tablets I.P 5 mg | Each film coated tablet contains: | |||
Escitalopram Oxalate eq.to Escitalopram | I.P. | 5 | mg | |||
Excipients | q.s. | |||||
Approved Colour used | ||||||
46 | Tablets | Escitalopram Tablets I.P 10 mg | Each film coated tablet contains: | |||
Escitalopram Oxalate eq.to Escitalopram | I.P. | 10 | mg | |||
Excipients | q.s. | |||||
Approved Colour used | ||||||
47 | Tablets | Escitalopram Tablets I.P 20 mg | Each film coated tablet contains: | |||
Escitalopram Oxalate Eq. to Escitalopram | I.P | 20 | mg | |||
Excipients | q.s. | |||||
Approved colour used | ||||||
48 | Tablets | Fexofenadine Hydrochloride Tablets I.P. 120 mg | Each film coated tablet contains : | |||
Fexofenadine Hydrochloride | I.P. | 120 | mg | |||
Excipients | q.s. | |||||
Approved Colour used | ||||||
49 | Tablets | Fexofenadine Hydrochloride Tablets I.P. 180 mg | Each film coated tablet contains : | |||
Fexofenadine Hydrochloride | I.P. | 180 | mg | |||
Excipients | q.s. | |||||
Approved Colour used | ||||||
50 | Tablets | Fexofenadine and Montelukast Tablets | Each chewable film coated tablet contains : | |||
Fexofenadine Hydrochloride | I.P. | 120 | mg | |||
Montelukast Sodium eq.to Montelukast | I.P. | 10 | mg | |||
Excipients | q.s. | |||||
Approved Colour used | ||||||
51 | Tablets | Atorvastatin Tablets I.P. 10 mg | Each film-coated tablet contains : | |||
Atorvastatin Calcium eq.to Atorvastatin | I.P. | 10 | mg | |||
Excipients | q.s. | |||||
Approved Colour used | ||||||
52 | Tablets | Atorvastatin Tablets I.P. 20 mg | Each film-coated tablet contains : | |||
Atorvastatin Calcium eq.to Atorvastatin | I.P. | 20 | mg | |||
Excipients | q.s. | |||||
Approved Colour used | ||||||
53 | Tablets | Atorvastatin Tablets I.P. 40 mg | Each film-coated tablet contains : | |||
Atorvastatin Calcium eq.to Atorvastatin | I.P. | 40 | mg | |||
Excipients | q.s. | |||||
Approved Colour used | ||||||
54 | Tablets | Atorvastatin Calcium and Fenofibrate Tablets | Each filmcoated tablet contains: | |||
“Atorvastatin Calcium | I.P | 10 | mg | |||
Fenofibrate | I.P | 160 | mg | |||
Excipients | q.s. | |||||
Approved colour used | ||||||
55 | Tablets | Atenolol Tablets I.P. 50 mg | Each uncoated tablet contains: | |||
Atenolol | I.P. | 50 | mg | |||
Excipients | q.s. | |||||
Approved colour used | ||||||
56 | Tablets | Atenolol Tablets I.P. 100 mg | Each uncoated tablet contains: | |||
Atenolol | I.P. | 100 | mg | |||
Excipients | q.s. | |||||
Approved colour used | ||||||
57 | Tablets | Methylprednisolone Tablets I.P. 4 mg | Each uncoated tablet contains : | |||
Methylprednisolone | I.P. | 4 | mg | |||
Excipients | q.s. | |||||
Approved Colour used | ||||||
58 | Tablets | Methylprednisolone Tablets 8 mg | Each uncoated tablet contains : | |||
Methylprednisolone | I.P. | 8 | mg | |||
Excipients | q.s. | |||||
Approved Colour used | ||||||
59 | Tablets | Methylprednisolone Tablets I.P. 16 mg | Each uncoated tablet contains : | |||
Methylprednisolone | I.P. | 16 | mg | |||
Excipients | q.s. | |||||
Approved Colour used | ||||||
60 | Tablets | Rosuvastatin Calcium Tablets I.P. 5 mg | Each film coated tablet contains: | |||
Rosuvastatin Calcium eq.to Rosuvastatin | I.P. | 5 | mg | |||
Excipients | q.s. | |||||
Approved Colour used | ||||||
61 | Tablets | Rosuvastatin Calcium Tablets I.P. 10 mg | Each film coated tablet contains: | |||
Rosuvastatin Calcium eq.to Rosuvastatin | I.P. | 10 | mg | |||
Excipients | q.s. | |||||
Approved Colour used | ||||||
62 | Tablets | Rosuvastatin Calcium Tablets I.P. 20 mg | Each film coated tablet contains: | |||
Rosuvastatin Calcium eq.to Rosuvastatin | I.P. | 20 | mg | |||
Excipients | q.s. | |||||
Approved Colour used | ||||||
63 | Tablets | “Rosuvastatin Calcium and Fenofibrate Tablets” | Each film coated tablet contains: | |||
Rosuvastatin Calcium eq.to Rosuvastatin | I.P. | 10 | mg | |||
Fenofibrate | I.P | 160 | mg | |||
Excipients | q.s. | |||||
Colour: | ||||||
64 | Tablets | Duloxetine Hydrochloride Tablets 20mg | Each enteric coated tablet contains: | |||
Duloxetine Hydrochloride eq.to Duloxetine | I.P | 20 | mg | |||
Excipients | q.s. | |||||
Approved Colour used | ||||||
65 | Tablets | Duloxetine Hydrochloride Tablets 30 mg | Each enteric coated tablet contains: | |||
Duloxetine Hydrochloride eq.to Duloxetine | I.P | 30 | mg | |||
Excipients | q.s. | |||||
Approved Colour used | ||||||
66 | Tablets | Telmisartan Tablets I.P. 20 mg | Each uncoated tablet contains : | |||
Telmisartan | I.P. | 20 | mg | |||
Excipients | q.s. | |||||
Approved Colour used | ||||||
67 | Tablets | Telmisartan Tablets I.P. 40 mg | Each uncoated tablet contains : | |||
Telmisartan | I.P. | 40 | mg | |||
Excipients | q.s. | |||||
Approved Colour used | ||||||
68 | Tablets | Telmisartan Tablets I.P. 80 mg | Each uncoated tablet contains : | |||
Telmisartan | I.P. | 80 | mg | |||
Excipients | q.s. | |||||
Approved Colour used | ||||||
69 | Tablets | Telmisartan 40 mg and Hydrochlorothiazide 12.5 mg Tablets I.P. | Each film coated tablet contains: | |||
Telmisartan | I.P. | 40 | mg | |||
Hydrochlorothiazide | I.P. | 12.5 | mg | |||
Excipients | q.s. | |||||
Approved Colour used | ||||||
70 | Tablets | Telmisartan 80 mg and Hydrochlorothiazide 12.5 mg Tablets I.P | Each film coated tablet contains: | |||
Telmisartan | I.P. | 80 | mg | |||
Hydrochlorothiazide | I.P. | 12.5 | mg | |||
Excipients | q.s. | |||||
Approved Colour used | ||||||
71 | Tablets | Telmisartan and Metoprolol Succinate (ER) Tablets | Each filmcoated tablet contains: | |||
Telmisartan | I.P | 40 | mg | |||
Metoprolol Succinate eq.to Metoprolol Tartrate (Extended Released) | I.P. | “47.550” | ||||
Excipients | q.s. | |||||
Approved Colour used | ||||||
72 | Tablets | Telmisartan, Amlodipine and Hydrochlorothiazide Tablets | Each uncoated tablet contains: | |||
Telmisartan | I.P. | 40 | mg | |||
“Amlodipine Besylate eq.to Amlodipine” | I.P. | 5 | mg | |||
Hydrochlorothiazide | I.P. | 12.5 | mg | |||
Excipients | q.s. | |||||
Approved Colour used | ||||||
73 | Tablets | Divalproex Extended Release Tablets I.P 250mg | Each film coated extended release tablet contain: | |||
Divalproex Sodium Eq. to Valproic Acid | I.P | 250 | mg | |||
Excipients | q.s | |||||
Approved Colour used | ||||||
74 | Tablets | Divalproex Extended Release Tablets I.P 500mg | Each film coated extended release tablet contain: | |||
Divalproex Sodium Eq. to Valproic Acid | I.P | 500 | mg | |||
Excipients | q.s | |||||
Approved Colour used | ||||||
75 | Tablets | “Divalproex Extended Release Tablets I.P 1000mg” | Each film coated extended release tablet contain: | |||
Divalproex Sodium Eq. to Valproic Acid | I.P | 1000 | mg | |||
Excipients | q.s | |||||
Approved Colour used | ||||||
76 | Tablets | Pantoprazole Gastro-resistant Tablets I.P. 40 mg | Each enteric-coated tablet contains: | |||
Pantoprazole Sodium eq.to Pantoprazole | I.P. | 40 | mg | |||
Excipients | q.s. | |||||
Approved Colour used | ||||||
77 | Tablets | Cetirizine Hydrochloride Tablets I.P. 10 mg | Each uncoated tablet contains : | |||
Cetirizine Hydrochloride | I.P. | 10 | mg | |||
Excipients | q.s. | |||||
Approved Colour used | ||||||
78 | Tablets | Levocetirizine Tablets I.P. 5 mg | Each uncoated tablet contains : | |||
Levocetirizine Hydrochloride | I.P. | 5 | mg | |||
Excipients | q.s. | |||||
Approved Colour used | ||||||
79 | Tablets | Betahistine Hydrochloride Tablets I.P. | Each film coated tablet contains : | |||
Betahistine Hydrochloride | I.P. | 16 | mg | |||
Excipients | q.s. | |||||
Approved Colour used | ||||||
80 | Tablets | Betahistine Hydrochloride Tablets I.P. | Each film coated tablet contains: | |||
Betahistine Hydrochloride | I.P. | 8 | mg | |||
Excipients | q.s. | |||||
Approved Colour used | ||||||
81 | Tablets | Paracetamol Tablets I.P. 650 mg | Each uncoated tablet contains : | |||
Paracetamol | I.P. | 650 | mg | |||
Excipients | q.s. | |||||
Approved Colour used | ||||||
82 | Tablets | “Serratiopeptidase Tablets I.P. 10 mg” | Each enteric coated tablet contains : | |||
“Serratiopeptidase | I.P. | 10 | mg | |||
Excipients | q.s. | |||||
Approved Colour used | ||||||
83 | Tablets | Febuxostat Tablets 40 mg | Each film coated tablet contains: | |||
Febuxostat | 40 | mg | ||||
Excipients | q.s. | |||||
Approved Colour used | ||||||
84 | Tablets | Febuxostat Tablets 80 mg | Each film coated tablet contains: | |||
Febuxostat | 80 | mg | ||||
Excipients | q.s. | |||||
Approved Colour used | ||||||
85 | Tablets | Voglibose Tablets I.P. 0.2 mg | Each uncoated tablet contains : | |||
Voglibose | I.P. | 0.2 | mg | |||
Excipients | q.s. | |||||
Approved Colour used | ||||||
86 | Tablets | Voglibose Tablets I.P. 0.3 mg | Each uncoated tablet contains : | |||
Voglibose | I.P. | 0.3 | mg | |||
Excipients | q.s. | |||||
Approved Colour used | ||||||
87 | Tablets | Hydroxyzine Tablets I.P. 10 mg | Each uncoated tablet contains: | |||
Hydroxyzine Hydrochloride | I.P. | 10 | mg | |||
Excipients | q.s. | |||||
Approved Colour used | ||||||
88 | Tablets | Hydroxyzine Tablets I.P. 25 mg | Each uncoated tablet contains: | |||
Hydroxyzine Hydrochloride | I.P. | 25 | mg | |||
Excipients | q.s. | |||||
Approved Colour used | ||||||
89 | Tablets | Citicoline Tablets I.P 500 mg | Each film coated tablet contains: | |||
Citicoline Sodium eq.to Citicoline | I.P. | 500 | mg | |||
Excipients | q.s. | |||||
Approved Colour used | ||||||
90 | Tablets | Loratadine Tablets I.P. | Each uncoated tablet contains: | |||
Loratadine | I.P. | 10 | mg | |||
Excipients | q.s. | |||||
Approved Colour used | ||||||
91 | Tablets | Olmesartan Medoxomil Tablets I.P. 20 mg | Each film coated tablet contains: | |||
Olmesartan Medoxomil | I.P. | 20 | mg | |||
Excipients | q.s. | |||||
Approved Colour used | ||||||
92 | Tablets | Olmesartan Medoxomil Tablets I.P. 40 mg | Each film coated tablet contains: | |||
Olmesartan Medoxomil | I.P. | 40 | mg | |||
Excipients | q.s. | |||||
Approved Colour used | ||||||
93 | Tablets | “Olmesartan Medoxomil 20 mg and Hydrochlorothiazide 12.5 mg Tablets I.P” | Each uncoated tablet contains: | |||
Olmesartan Medoxomil | I.P | 20 | mg | |||
Hydrochlorothiazide | I.P | 12.5 | mg | |||
Excipients | q.s. | |||||
Approved colour used | ||||||
94 | Tablets | Olmesartan Medoxomil and Amlodipine Tablets | Each uncoated tablet contains: | |||
Olmesartan Medoxomil | I.P | 40 | mg | |||
Amlodipine Besylate eq.to Amlodipine | I.P. | 5 | mg | |||
Excipients | q.s. | |||||
Approved colour used | ||||||
95 | Tablets | Linezolid Tablets I.P. | Each film coated tablet contains: | |||
Linezolid | I.P. | 600 | mg | |||
Excipients | q.s. | |||||
Approved Colour used | ||||||
96 | Tablets | Losartan Potassium Tablets I.P. 50 mg | Each film coated tablet contains: | |||
Losartan Potassium | I.P. | 50 | mg | |||
Excipients | q.s. | |||||
Approved Colour used | ||||||
97 | Tablets | Losartan Potassium and Amlodipine Tablets I.P. | Each film coated tablet contains: | |||
Losartan Potassium | I.P. | 50 | mg | |||
Amlodipine Besilate eq.to Amlodipine | I.P. | 5 | mg | |||
Excipients | q.s. | |||||
Approved Colour used | ||||||
98 | Tablets | Losartan Potassium and Hydrochlorothiazide Tablets I.P. | Each film coated tablet contains: | |||
Losartan Potassium | I.P. | 50 | mg | |||
Hydrochlorothiazide | I.P. | 12.5 | mg | |||
Excipients | q.s. | |||||
Approved Colour used | ||||||
99 | Tablets | Metformin Hydrochloride Sustained Released Tablets I.P. | Each uncoated tablet contains: | |||
Metformin Hydrochloride (sustained released) | I.P. | 500 | mg | |||
Excipients | q.s. | |||||
Approved Colour used | ||||||
100 | Tablets | Amlodipine Besilate Tablets I.P. | Each film coated tablet contains: | |||
Amlodipine Besilate eq.to Amlodipine | I.P. | 5 | mg | |||
Excipients | q.s. | |||||
Approved Colour used | ||||||
101 | Tablets | “Amlodipine Besilate and Atenolol Tablets I.P.” | Each uncoated tablet contains: | |||
Amlodipine Besilate eq.to Amlodipine | I.P. | 5 | mg | |||
Atenolol | I.P. | 50 | mg | |||
Excipients | q.s. | |||||
Approved Colour used | ||||||
102 | Tablets | Amlodipine Besylate and Metoprolol Succinate (ER)Tablets | Each uncoated tablet contains: | |||
Amlodipine Besylate Eq.to Amlodipine | I.P. | 5 | mg | |||
Metoprolol Succinate eq.to Metoprolol Tartrate (Extended Released) | I.P. I.P | “47.50” | mg | |||
Excipients | q.s. | |||||
Approved Colour used | ||||||
103 | Tablets | “Diclofenac Sodium and Paracetamol Tablets I.P | Each uncoated tablet contains : | |||
Diclofenac Sodium | I.P. | 50 | mg | |||
Paracetamol | I.P. | 325 | mg | |||
Excipients | q.s. | |||||
Approved Colour used | ||||||
104 | Tablets | Mefenamic Acid and Dicyclomine HCl Tablets I.P | Each uncoated tablet contains : | |||
Mefenamic Acid | I.P. | 250 | mg | |||
Dicyclomine Hydrochloride | I.P. | 10 | mg | |||
Excipients | q.s. | |||||
Approved Colour used | ||||||
105 | Tablets | Metoprolol Succinate (ER) Tablets I.P. | Each film coated tablet contains: | |||
Metoprolol Succinate eq.to Metoprolol Tartrate (extended released) | I.P. I.P | “23.7525” | mg | |||
Excipients | q.s. | |||||
Approved Colour used | ||||||
106 | Tablets | Metoprolol Succinate (ER) Tablets I.P. | Each film coated tablet contains: | |||
Metoprolol Succinate eq.to Metoprolol Tartrate (extended released) | “I.P.” | “47.50” | mg | |||
Excipients | q.s. | |||||
Approved Colour used | ||||||
107 | Tablets | Lornoxicam and Paracetamol Tablets | Each film coated tablet contains : | |||
Lornoxicam | 4 | mg | ||||
Paracetamol | I.P. | 325 | mg | |||
Excipients | q.s. | |||||
Approved Colour used | ||||||
108 | Tablets | Lornoxicam and Paracetamol Tablets | Each film coated tablet contains: | |||
Lornoxicam | 8 | mg | ||||
Paracetamol | I.P. | 325 | mg | |||
Excipients | q.s. | |||||
Approved Colour used | ||||||
109 | Tablets | Aceclofenac Sustained Released Tablets 200mg | Each uncoated sustained released tablet contains : | |||
Aceclofenac | I.P. | 200 | mg | |||
Excipients | q.s. | |||||
Approved Colour used | ||||||
110 | Tablets | Montelukast and Levocetirizine Hydrochloride Tablets I.P | Each film coated tablet contains : | |||
Levocetirizine Hydrochloride | I.P. | 2.5 | mg | |||
Montelukast Sodium eq.to Montelukast | I.P. | 4 | mg | |||
Excipients | q.s. | |||||
Approved Colour used | ||||||
111 | Tablets | Glucosamine, Methylsulphonylmethane and Diacerein Tablets | Each film coated tablet contains : | |||
“Glucosamine Sulphate Potassium Chloride | USP | “750/446” | mg | |||
Methylsulphonylmethane | USP | 250 | mg | |||
Diacerein | I.P. | 50 | mg | |||
Excipients | q.s. | |||||
Approved Colour used | ||||||
112 | Tablets | Diclofenac Sodium and Serratiopeptidase Tablets | Each enteric coated tablet contains : | |||
Diclofenac Sodium | B.P. | 50 | mg | |||
“Serratiopeptidase | I.P. | 10 | mg | |||
Excipients | q.s. | |||||
Approved Colour used | ||||||
113 | Tablets | Etoricoxib and Paracetamol Tablets | Each film coated tablet contains: | |||
Etoricoxib | I.P. | 60 | mg | |||
Paracetamol | I.P. | 325 | mg | |||
Excipients | q.s. | |||||
Approved Colour used | ||||||
114 | Tablets | Tranexamic Acid and Mefenamic Acid Tablets | Each film coated tablet contains : | |||
Tranexamic Acid | I.P. | 500 | mg | |||
Mefenamic Acid | I.P. | 250 | mg | |||
Excipients | q.s. | |||||
Approved Colour used | ||||||
115 | Tablets | Levocetirizine Hydrochloride and Ambroxol Hydrochloride (SR) Tablets | Each uncoated sustained released tablet contains : | |||
Levocetirizine Hydrochloride | I.P. | 5 | mg | |||
Ambroxol Hydrochloride (as sustained released) | I.P. | 75 | mg | |||
Excipients | q.s. | |||||
Approved Colour used | ||||||
116 | Tablets | Aceclofenac and Thiocolchicoside Tablets | Each film coated tablet contains : | |||
Aceclofenac | I.P. | 100 | mg | |||
Thiocolchicoside | I.P. | 8 | mg | |||
Excipients | q.s. | |||||
Approved Colour used | ||||||
117 | Tablets | Trypsin,Bromelain and Rustoside Trihydrate Tablets | Each enteric coated tablet contains : | |||
Trypsin | B.P. | 48 | mg | |||
Bromelain | 90 | mg | ||||
Rustoside Trihydrate | B.P. | 100 | mg | |||
Excipients | q.s. | |||||
Approved Colour used | ||||||
118 | Tablets | Trypsin,Bromelain, Rustoside Trihydrate and Diclofenac Sodium Tablets | Each enteric coated tablet contains : | |||
Trypsin | B.P. | 48 | mg | |||
Bromelain | 90 | mg | ||||
Rustoside Trihydrate | B.P. | 100 | mg | |||
Diclofenac Sodium | I.P. | 50 | mg | |||
Excipients | q.s. | |||||
Approved Colour used | ||||||
119 | Tablets | Terbinafine Tablets I.P 250 mg | Each uncoated tablet contains: | |||
Terbinafine Hydrochloride eq.to Terbinafine | I.P | 250 | mg | |||
Excipients | q.s. | |||||
Approved Colour used | ||||||
120 | Tablets | Levosulpride Tablets | Each film coated tablet contains: | |||
Levosulpride | 50 | mg | ||||
Excipients | q.s. | |||||
Approved Colour used | ||||||
121 | Tablets | Eperisone Hydrochloride and Paracetamol Tablets | Each film coated tablet contains: | |||
Eperisone Hydrochloride | 50 | mg | ||||
Paracetamol | I.P. | 325 | mg | |||
Excipients | ||||||
Approved Colour used | ||||||
122 | Tablets | Cinnarizine and Domperidone Tablets | Each uncoated tablet contains: | |||
Cinnarizine | I.P. | 20 | mg | |||
Domperidone | I.P. | 15 | mg | |||
Excipients | ||||||
Approved Colour used | ||||||
123 | Tablets | Tolperisone HCl and Diclofenac Sodium Tablets | Each uncoated tablet contains: | |||
Tolperisone Hydrochloride | 150 | mg | ||||
Diclofenac Sodium | I.P. | 50 | mg | |||
Excipients | q.s. | |||||
Approved colour used | ||||||
124 | Tablets | “Sildenafil Citrate Tablets I.P. 50 mg” | Each film-coated tablet contains : | |||
Sildenafil Citrate eq.to Sildenafil | I.P. | 50 | mg | |||
Excipients | q.s. | |||||
Approved Colour used | ||||||
125 | Tablets | Amisulpiride Tablets IP 50 mg | Each film coated tablet contains: | |||
Amisulpride | I.P | 50 | mg | |||
Excipients | q.s. | |||||
Approved colour used | ||||||
126 | Tablets | Ketoconazole Tablets I.P 200mg | Each film coated tablet contains: | |||
Ketoconazole | I.P | 200 | mg | |||
Excipients | q.s. | |||||
Approved colour used | ||||||
127 | Tablets | Ketorolac Tromethamine Dispersible Tablets 10mg | Each uncoated dispersible tablet contains : | |||
Ketorolac Tromethamine | I.P | 10 | mg | |||
Excipients | q.s. | |||||
Approved Colour used | ||||||
128 | Tablets | Drotaverine Hydrochloride and Mefenamic Acid Tablets | Each film coated tablet contains : | |||
Drotaverine Hydrochloride | I.P | 80 | mg | |||
Mefenamic Acid | I.P. | 250 | mg | |||
Excipients | q.s. | |||||
Approved Colour used | ||||||
129 | Tablets | Citicoline and Piracetam Tablets | Each film coated tablet contains: | |||
Citicoline Sodium eq.to Citicoline | I.P. | 500 | mg | |||
Piracetam | I.P. | 400 | mg | |||
Excipients | q.s. | |||||
Approved Colour used | ||||||
130 | Tablets | Metformin HCl Prolonged release and Glimepiride Tablets I.P | Each uncoated bilayred tablet contains: | |||
Metformin Hydrochloride (In Prolonged release form) | I.P. | 500 | mg | |||
Glimepiride | I.P. | 1 | mg | |||
Excipients | q.s. | |||||
Approved Colour used | ||||||
131 | Tablets | Metformin HCl Prolonged release and Glimepiride Tablets I.P | Each uncoated bilayred tablet contains: | |||
Metformin Hydrochloride (In Prolonged release form) | I.P. | 500 | mg | |||
Glimepiride | I.P. | 2 | mg | |||
Excipients | q.s. | |||||
Approved Colour used | ||||||
132 | Tablets | Vildagliptin and Metformin Hydrochloride Tablets | Each film coated tablet contains: | |||
Vildagliptin | I.P | 50 | mg | |||
Metformin Hydrochloride | I.P. | 500 | mg | |||
Excipients | q.s. | |||||
Approved Colour used | ||||||
133 | Tablets | Vildagliptin and Metformin Hydrochloride Tablets | Each film coated tablet contains: | |||
Vildagliptin | I.P | 50 | mg | |||
Metformin Hydrochloride | I.P. | 850 | mg | |||
Excipients | q.s. | |||||
Approved Colour used | ||||||
134 | Tablets | Vildagliptin and Metformin Hydrochloride Tablets | Each film coated tablet contains: | |||
Vildagliptin | I.P | 50 | mg | |||
Metformin Hydrochloride | I.P. | 1000 | mg | |||
Excipients | q.s. | |||||
Approved Colour used | ||||||
135 | Tablets | “Tamsulosin HCl (MR) and Dutasteride Tablets” | Each film coated tablet contains: | |||
Tamsulosin Hydrochloride (as modified release) | I.P | 0.4 | mg | |||
Dutasteride | I.P | 0.5 | mg | |||
Excipients | q.s. | |||||
Approved colour used | ||||||
136 | Tablets | Levetiracetam Tablets I.P | Each film coated tablet contains: | |||
Levetiracetam | I.P | 500 | mg | |||
Excipients | q.s. | |||||
Approved colour used | ||||||
137 | Tablets | Fexofenadine and Montelukast Chewable Tablets | Each uncoated chewable tablet contains : | |||
Fexofenadine Hydrochloride | I.P. | 120 | mg | |||
Montelukast Sodium eq.to Montelukast | I.P. | 10 | mg | |||
Excipients | q.s. | |||||
Approved Colour used | ||||||
138 | Tablets | Sitagliptin Phosphate and Metformin Hydrochloride Tablets | Each film coated tablet contains: | |||
Sitagliptin Phosphate Monohydrate Eq. to Sitagliptin | I.P | 50 | mg | |||
Metformin Hydrochloride | I.P. | 500 | mg | |||
Excipients | q.s. | |||||
Approved Colour used | ||||||
139 | Tablets | Flupentixol and Melitracen Tablets | Each film coated tablet contains: | |||
Flupentixol Hydrochloride Eq. to Flupentixol | B.P | 0.5 | mg | |||
Melitracen Hydrochloride Eq to Melitracen | 10 | mg | ||||
Excipients | q.s. | |||||
Approved colour used | ||||||
140 | Tablets | Combipack of Mifepristone and Misoprostol Tablets | Each pack contains: | |||
A} 1 Mifepristone Tablets I.P | ||||||
Each uncoated tablet contains: | ||||||
Mifepristone | I.P | 200 | mg | |||
Excipients | q.s | |||||
B} 4 Misoprostol Tablets I.P | ||||||
Each uncoated tablet contains: | ||||||
Misoprostol | I.P | 200 | mcg | |||
Excipients | q.s. | |||||
141 | Tablets | Paracetamol, Phenylephrine HCl and Cetirizine HCl Tablets | Each uncoated tablet contains: | |||
Paracetamol | I.P | 325 | mg | |||
Phenylephrine Hydrochloride | I.P | 5 | mg | |||
Cetirizine Hydrochloride | I.P | 5 | mg | |||
Excipients | q.s. | |||||
Approved colour used | ||||||
142 | Tablets | Teneligliptin and Metformin Hydrochloride (ER)Tablets | Each uncoated bilayered tablet contains: | |||
Teneligliptin Hydrobromide Hydrate eq. to Teneligliptin | I.P | 20 | mg | |||
Metformin Hydrochloride (as extended release) | I.P. | 500 | mg | |||
Excipients | q.s. | |||||
Approved Colour used | ||||||
143 | Tablets | Naproxen and Domperidone Tablets | Each film coated tablet contains: | |||
Naproxen | I.P | 500 | mg | |||
Domperidone | I.P | 10 | mg | |||
Excipients | q.s. | |||||
Approved colour used | ||||||
144 | Tablets | Levocetirizine Dihydrochloride, Montelukast and Ambroxol HCl (SR) Tablets | Each film coated tablet contains : | |||
Levocetirizine Dihydrochloride | I.P. | 5 | mg | |||
Montelukast Sodium eq.to Montelukast | I.P. | 10 | mg | |||
Ambroxol Hydrochloride (as sustained release) | I.P | 75 | mg | |||
Excipients | q.s. | |||||
Approved Colour used | ||||||
145 | Tablets | Acebrophylline Sustained Release, Fexofenadine HCl and Montelukast Tablets | Each film coated tablet contains : | |||
“Acebrophylline | 200 | mg | ||||
Fexofenadine Hydrochloride | I.P. | 120 | mg | |||
Montelukast Sodium eq.to Montelukast | I.P. | 10 | mg | |||
Excipients | q.s. | |||||
Approved Colour used | ||||||
146 | Tablets | Ferrous Ascorbate, Folic acid and Zinc Sulphate Monohydrate Tablets | Each film coated tablet contains: | |||
Ferrous Ascorbate | I.P | 100 | mg | |||
Folic Acid | I.P. | 1.5 | mg | |||
Zinc Sulphate Monohydrate eq. to elemental zinc | I.P. | 22.5 | mg | |||
Excipients | q.s. | |||||
Approved Colour used | ||||||
147 | Tablets | “Aceclofenac, Paracetamol,Cetirizine Dihydrochloride, Phenylephrine HCl and CaffeineTablets | Each uncoated tablet contains : | |||
Aceclofenac | I.P. | 100 | mg | |||
Paracetamol | I.P. | 325 | mg | |||
Cetirizine Dihydrochloride | I.P | 10 | mg | |||
Phenylephrine Hydrochloride | I.P | 5 | mg | |||
Caffeine | I.P. | 25 | mg | |||
Excipients | q.s. | |||||
Approved Colour used | ||||||
147 | Tablets | Doxylamine Succinate, Pyridoxine HCl & Folic Acid Tablets | Each enteric coated tablet contains : | |||
Doxylamine Succinate | USP | 10 | mg | |||
Pyridoxine Hydrochloride | I.P. | 10 | mg | |||
Folic Acid | I.P | 2.5 | mg | |||
Excipients | q.s. | |||||
Approved Colour used | ||||||
148 | Tablets | Rabeprazole and Ondansetron Tablets | Each enteric coated tablet contains : | |||
Rabeprazole Sodium | I.P. | 20 | mg | |||
“Ondansetron Hydrochloride | I.P. | 4 | mg | |||
Excipients | q.s. | |||||
Approved Colour used | ||||||
149 | Tablets | Diclofenac Potassium and Serratiopeptidase Tablets | Each enteric coated tablet contains : | |||
Diclofenac Pottasium | B.P. | 50 | mg | |||
“Serratiopeptidase | I.P. | 10 | mg | |||
Excipients | q.s. | |||||
Approved Colour used | ||||||
150 | Tablets | “Glimepiride, MetforminHCl (SR) and Pioglitazone Tablets | Each uncoated bilayered tablet contains: | |||
Glimepiride | I.P. | 2 | mg | |||
Metformin Hydrochloride (In sustained release form) | I.P. | 500 | mg | |||
Pioglitazone Hydrochloride eq. to Pioglitazone | I.P | 15 | mg | |||
Excipients | q.s. | |||||
Approved Colour used | ||||||
151 | Tablets | “Glimepiride, Metformin | Each uncoated bilayered tablet contains: | |||
Glimepiride | I.P. | 1 | mg | |||
Metformin Hydrochloride (In sustained release form) | I.P. | 500 | mg | |||
Pioglitazone Hydrochloride eq. to Pioglitazone | I.P | 15 | mg | |||
Excipients | q.s. | |||||
Approved Colour used | ||||||
152 | Tablets | “Diclofenac Potassium Paracetamol and Serratiopeptidase Tablets | Each film coated tablets contains : | |||
Diclofenac Potassium | B.P | 50 | mg | |||
Paracetamol | I.P. | 325 | mg | |||
“Serratiopeptidase | I.P | 10 | mg | |||
Excipients | q.s. | |||||
Approved Colour used | ||||||
153 | Tablets | Metoprolol Succinate (ER) Tablets I.P. | Each uncoated extended release tablet contains: | |||
Metoprolol Succinate eq.to Metoprolol Tartrate (extended released) | I.P | “23.7525” | mg | |||
Excipients | q.s. | |||||
Approved Colour used | ||||||
154 | Tablets | Metoprolol Succinate (ER) Tablets I.P. | Each uncoated extended release tablet contains: | |||
Metoprolol Succinate eq.to Metoprolol Tartrate (extended released) | “I.P. | “47.50 | mg | |||
Excipients | q.s. | |||||
Approved Colour used | ||||||
155 | Tablets | Telmisartan 80 mg and Chlorthalidone 12.5 mg Tablets | Each film coated tablet contains: | |||
Telmisartan | I.P. | 80 | mg | |||
Chlorthalidone | I.P. | 12.5 | mg | |||
Excipients | q.s. | |||||
Approved Colour used | ||||||
156 | Tablets | Telmisartan 40 mg and Chlorthalidone 12.5 mg Tablets | Each film coated tablet contains: | |||
Telmisartan | I.P. | 40 | mg | |||
Chlorthalidone | I.P. | 12.5 | mg | |||
Excipients | q.s. | |||||
Approved Colour used | ||||||
157 | Tablets | Fexofenadine and Montelukast Tablets | Each film coated tablet contains : | |||
Fexofenadine Hydrochloride | I.P. | 120 | mg | |||
Montelukast Sodium eq.to Montelukast | I.P. | 10 | mg | |||
Excipients | q.s. | |||||
Approved Colour used | ||||||
158 | Tablets | Aceclofenac and Paracetamol Tablets | Each uncoated tablet contains : | |||
Aceclofenac | I.P. | 100 | mg | |||
Paracetamol | I.P. | 325 | mg | |||
Excipients | q.s. | |||||
Approved Colour used | ||||||
159 | Tablets | Lansoprazole Orally Disintegrating Tablets | Each uncoated tablet contains : | |||
“Lansoprazole | I.P. | 15 | mg | |||
Excipients | q.s. | |||||
Approved Colour used | ||||||
160 | Tablets | Dextromethorphan Hydrobromide, Chlorpheniramine Maleate and Phenylepherine Hydrochloride Tablets | Each uncoated tablet contains : | |||
Dextromethorphan Hydrobromide | I.P. | 10 | mg | |||
Chlorpheniramine Maleate | I.P. | 2 | mg | |||
Phenylepherine Hydrochloride | I.P. | 5 | mg | |||
Excipients | q.s. | |||||
Colour: Ponceau-4R | ||||||
161 | Tablets | Metformin Hydrochloride Sustained Released Tablets I.P. | Each uncoated sustained release tablet contains: | |||
Metformin Hydrochloride | I.P. | 1000 | mg | |||
Excipients | q.s. | |||||
Approved Colour used | ||||||
162 | Tablets | Rosuvastatin Calcium Tablets I.P. 40 mg | Each film coated tablet contains: | |||
Rosuvastatin Calcium eq.to Rosuvastatin | I.P. | 40 | mg | |||
Excipients | q.s. | |||||
Approved Colour used | ||||||
163 | Tablets | Citicoline and Piracetam Tablets | Each film coated tablet contains: | |||
Citicoline Sodium eq.to Citicoline | I.P. | 500 | mg | |||
Piracetam | I.P. | 800 | mg | |||
Excipients | q.s. | |||||
Approved Colour used |